Physician profile
Jonathan Ramin
NPI 1336502079
$858.32
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $108 · 2021: $76.95 · 2022: $14.54 · 2023: $326 · 2024: $183 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $201.72 | 2023-2024 | Sprint Pns System |
| Allergan, INC. | $107.63 | 2020 | |
| Merz Pharmaceuticals, LLC | $104.79 | 2023 | Xeomin |
| Medtronic, INC. | $76.95 | 2021 | |
| Orthofix Medical, INC. | $49.47 | 2024 | Physio-Stim, Accelstim |
| Amgen INC. | $48.90 | 2025 | Evenity |
| Ferring Pharmaceuticals INC. | $47.39 | 2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $42.70 | 2024 | Exparel, Iovera, Zilretta |
| Nalu Medical, INC. | $36.52 | 2025 | Nalu Neurostimulation System |
| Sanofi-Aventis U.S. LLC | $30.42 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $28.77 | 2025 | |
| Depuy Synthes Sales INC. | $18.38 | 2025 | Orthovisc |
| Fidia Pharma USA INC. | $18.23 | 2024 | Hymovis, Triluron, Hyalgan |
| Boston Scientific Corporation | $17.44 | 2025 | Intracept |
| Bioventus LLC | $14.54 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $14.47 | 2023 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ramin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.